Marko Ravic

Dr. Marko Ravic

Department Of Pharmacy, University of Kragujevac, Faculty of medical sciences, Kragujevac, Serbia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
JBJovana Bradic
Jovana Bradic
VZVladimir Zivkovic
Vladimir Zivkovic
ISIvan M. Srejovic
Ivan M. Srejovic
Vladimir JakovljevicVladimir Jakovljevic
Vladimir Jakovljevic
APAnica Petrovic
Anica Petrovic
MTMarina Tomović
Marina Tomović
Galium verum L. (G.verum,lady’s bedstraw) is a perennial herbaceous plant, belonging to the Rubiaceae family. It has been widely used throughout history due to multiple therapeutic properties. However, the effects of this plant species on functional recovery of the heart after ischemia have still not been fully clarified. Therefore, the aim of our study was to examine the effects of methanol extract ofG. verumon myocardial ischemia/reperfusion (I/R) injury in spontaneously hypertensive rats (SHR), with a special emphasis on the role of oxidative stress. Rats involved in the research were divided randomly into two groups: control (spontaneously hypertensive rats (SHR)) andG. verumgroup, including SHR rats treated with theG. verumextract (500 mg/kg body weight per os) for 4 weeks. At the end of the treatment,in vivocardiac function was assessed by echocardiography. Rats were sacrificed and blood samples were taken for spectrophotometric determination of systemic redox state. Hearts from all rats were isolated and retrogradely perfused according to theLangendorfftechnique. After a stabilization period, hearts were subjected to 20-minute ischemia, followed by 30-minute reperfusion. Levels of prooxidants were spectrophotometrically measured in coronary venous effluent, while antioxidant enzymes activity was assessed in heart tissue. Cell morphology was evaluated by hematoxylin and eosin (HE) staining. 4-week treatment withG. verumextract alleviated left ventricular hypertrophy and considerably improvedin vivocardiac function. Furthermore,G. verumextract preserved cardiac contractility, systolic function, and coronary vasodilatory response after ischemia. Moreover, it alleviated I/R-induced structural damage of the heart. Additionally,G. verumextract led to a drop in the generation of most of the measured prooxidants, thus mitigating cardiac oxidative damage. Promising potential ofG. verumin the present study may be a basis for further researches which would fully clarify the mechanisms through which this plant species triggers cardioprotection.

11 October 2018 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
BJBiljana Jakovljevic
Biljana Jakovljevic
TTTamara R Nikolic Turnic
Tamara R Nikolic Turnic
NJNevena Jeremic
Nevena Jeremic
Jovana NovakovicJovana Novakovic
Jovana Novakovic
JBJovana Bradic
Jovana Bradic
VZVladimir Zivkovic
Vladimir Zivkovic

19 April 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MRMarko Ravic
Marko Ravic
ISIvan M. Srejovic
Ivan M. Srejovic
Jovana NovakovicJovana Novakovic
Jovana Novakovic
MAMarijana Andjic
Marijana Andjic
Jasmina SretenovicJasmina Sretenovic
Jasmina Sretenovic
Vladimir JakovljevicVladimir Jakovljevic
Vladimir Jakovljevic
Metabolic syndrome (MetS) represents an important factor that increases the risk of myocardial infarction, and more severe complications. Glucagon Like Peptide-1 Receptor Agonists (GLP-1RAs) exhibit cardioprotective potential, but their efficacy in MetS-related myocardial dysfunction has not been fully explored. Therefore, we aimed to assess the effects of exenatide and dulaglutide on heart function and redox balance in MetS-induced rats. Twenty-four Wistar albino rats with induced MetS were divided into three groups: MetS, exenatide-treated (5 µg/kg), dulaglutide-treated (0.6 mg/kg). After 6 weeks of treatment, in vivo heart function was assessed via echocardiography, while ex vivo function was evaluated using a Langendorff apparatus to simulate ischemia-reperfusion injury. Heart tissue samples were analyzed histologically, and oxidative stress biomarkers were measured spectrophotometrically from the coronary venous effluent. Both exenatide and dulaglutide significantly improved the ejection fraction by 3% and 7%, respectively, compared to the MetS group. Histological analyses corroborated these findings, revealing a reduction in the cross-sectional area of cardiomyocytes by 11% in the exenatide and 18% in the dulaglutide group, indicating reduced myocardial damage in GLP-1RA-treated rats. Our findings suggest strong cardioprotective potential of GLP-1RAs in MetS, with dulaglutide showing a slight advantage. Thus, both exenatide and dulaglutide are potentially promising targets for cardioprotection and reducing mortality in MetS patients.

1 March 2021 in Serbian Journal of Experimental and Clinical Research
Verified
Journal Article
Open access
PDF file
ASAleksandra Stojanovic
Aleksandra Stojanovic
AAAleksandra Antovic
Aleksandra Antovic
NLNevena Lazarevic
Nevena Lazarevic
MAMarijana Andjic
Marijana Andjic
MRMarko Ravic
Marko Ravic
MVMirjana Veselinovic
Mirjana Veselinovic
The aim of this study was to assess oxidative status and to set baseline characteristics for female population with established rheumatoid arthritis. Total of 42 patients with rheumatoid arthritis and 48 age- and sex-matched controls were included in the study. Clinical examination was performed and assessed disease activity. Peripheral blood samples were used for all the assays. The markers of oxidative stress were assessed, including plasma levels of index of lipid peroxidation – thiobarbituric acid reactive substances, hydrogen peroxide, superoxide anion radical, nitrites and activity of superoxide dismutase, catalase and reduced glutathione levels as anti-oxidant parameters. In the patients group, levels of hydrogen peroxide and index of lipid peroxidation were higher than in controls. Patients with rheumatoid arthritis had decreased su-peroxide dismutase and catalase activity compared to healthy subjects. Interestingly, controls had higher levels of nitrites compared to patients. Patients showed a marked increase in reactive oxygen species formation and lipid peroxidation as well as decrease in the activity of antioxidant defense system leading to oxidative stress which may contribute to tissue and cartilage damage and hence to the chronicity of the disease.

1 September 2020 in Serbian Journal of Experimental and Clinical Research
Verified
Journal Article
Open access
PDF file
MRMarko Ravic
Marko Ravic
VJVladimir Jakovljevic
Vladimir Jakovljevic
PRPetar Ristic
Petar Ristic
ISIvan Srejovic
Ivan Srejovic
ASAleksandra Stojanovic
Aleksandra Stojanovic
SBSergey Bolevich
Sergey Bolevich
Diabetes mellitus is a major risk factor for cardiovascular diseases, while cardiovascular diseases are a leading cause of morbidity and mortality worldwide. The renin–angiotensin– aldosterone system controls renal, cardiovascular, adrenal function and regulates fluid and electrolyte balance as well as blood pressure. Because of his role, inhibition of reninangiotensin-aldosteron system is another therapy approach that reduces the risk of diabetes and cardiovascular disease. In this study, our goal was to evaluate effect of valsartan,as inhibitor of angiotensin II receptor type 1, on cardiac tissue and function, with focus on cardiodynamic and oxidative stress. The present study was carried out on 20 adult male Wistar albino rats (8 week old and with body masses of 180-200 g). Rats were divided randomly into 2 groups (10 animals per group). Healthy animals treated with 1 μM of valsartan and streptozotocin-induced diabetic animals perfused with 1 μM of valsartan 4 weeks after the induction of diabetes. Our results demonstrated that acute application of valsartan has different effect on cardiodynamics in rat heart of diabetic and healthy animals but did not improve cardiac function in hyperglycemia-induced changes. A challenge for further investigations are studies with chronic or acute administration, alone or in combination with other angiotensin-converting-enzyme inhibitor in various models of diabetes.

14 May 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
MMMaja Dragan Murić
Maja Dragan Murić
ISIvan M. Srejovic
Ivan M. Srejovic
MRMarko Ravic
Marko Ravic
Jovana Joksimovic JovicJovana Joksimovic Jovic
Jovana Joksimovic Jovic
Jasmina SretenovicJasmina Sretenovic
Jasmina Sretenovic
Jovana NovakovicJovana Novakovic
Jovana Novakovic
Background/Objectives: This study aimed to clarify the cardioprotective effects of combined empagliflozin and sacubitril/valsartan therapy in an experimental rat model of heart failure (HF). The main research question was whether dual treatment provides greater functional and molecular benefit than either monotherapy, with particular emphasis on oxidative stress, inflammation, apoptosis, and JAK2/STAT3 signaling. Methods: HF was induced in rats by 7-day isoproterenol administration and confirmed four weeks later by echocardiographic evidence of reduced ejection fraction (<55%). The animals were then assigned to healthy control, untreated HF, empagliflozin, sacubitril/valsartan, and combined empagliflozin/sacubitril/valsartan groups. Following four weeks of treatment, ex vivo cardiac function was evaluated using the Langendorff technique. Serum cardiospecific markers and natriuretic peptides were measured by ELISA. Oxidative stress parameters were determined in coronary venous effluent, while myocardial gene expression of selected (anti)oxidative, (anti)inflammatory, (anti)apoptotic, and signaling markers was assessed by RT-PCR. Myocardial collagen content was evaluated using Picrosirius red staining. Results: HF rats exhibited impaired ex vivo myocardial function, elevated cardiac injury markers, increased oxidative stress, upregulation of pro-inflammatory and pro-apoptotic genes, activation of JAK2/STAT3 signaling, and increased myocardial collagen content. Both monotherapies produced partial benefit. In contrast, combined treatment achieved the most pronounced improvement in contractile performance, attenuated oxidative stress more consistently, reduced expression of TNF-α, IL-1β, IL-6, IL-17, Bax, CASP-3, and CASP-9, favorably modulated JAK2, STAT3, mTOR, and PPARγ expression, and decreased myocardial collagen content. Conclusions: Dual empagliflozin and sacubitril/valsartan therapy exerted broader cardioprotective effects than either monotherapy, likely through coordinated antioxidant, anti-inflammatory, anti-apoptotic, and signaling-related mechanisms.